Domestic API Capacity AMPAC Fine Chemicals is a US-based custom API manufacturer with facilities in California, Texas, and Virginia, offering cGMP compliant production from kilograms to multi-tonne quantities. This presents a sales opportunity to expand relationships with US-based pharma companies seeking reliable domestic supply for critical APIs and drug substances, including HPAPI capabilities and high-potency workflows.

Strategic Partnerships The company is part of the SK pharmteco group and has a track record of collaboration on national initiatives to secure domestic pharmaceutical ingredients through partnerships (e.g., Phlow, Civica Rx) and federal programs. This suggests a potential to engage in co-development or contracted manufacturing aligned with U.S. supply chain resilience initiatives.

Advanced Technology AFC highlights capabilities in hazardous/energetic chemistries, high-containment HPAPI production, SMB chromatography, continuous processing, and standalone analytical labs. These capabilities can be positioned to customers needing complex, scalable, and compliant production solutions with robust process development and analytical support.

Regulatory & Compliance The facility operates under cGMP and ISO/IEC 27001 with an emphasis on controlled substances and specialized chemistries, plus past EPA remediation matters. Sales conversations can emphasize strong quality systems, regulatory compliance, and data security, while offering risk-mitigated manufacturing partnerships.

Growth & Scale With revenue in the mid-range and a recent history of capacity expansion, headcount growth, and ongoing collaboration on U.S. domestic supply programs, AFC appears positioned to scale with customers pursuing long-term supply commitments, enabling upsell to bigger batch sizes, broader API portfolios, and on-site development support.